The main risk is not reactor science but commercial conversion. NuScale has a genuine regulatory and trust advantage, plus liquidity, yet value creation still depends on a small number of contracts becoming financeable, licensable, and manufacturable projects before delay,
dilution, or better-capitalized rivals narrow the window.